Eyenovia, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
EYEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
295 Madison Avenue,, Suite 2400, New York, New York

Insiders trading volume in the past year

Eyenovia, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stuart M. Grant 10%+ Owner $7.2M +$1.18M +19.5% Jul 2, 2024
Fredric N. Eshelman Director $1.77M Nov 17, 2021
Tsontcho Ianchulev Director $1.39M Jun 12, 2024
Ernest Mario Director $520K Nov 17, 2021
Charles E. Mather IV Director $213K Jun 12, 2024
Ellen R. Strahlman Director $186K +$8.1K +4.56% Jun 12, 2024
Rachel Jacobson Director $142K Jun 12, 2024
Ram Palanki Director $135K Jun 12, 2024
Jennifer Clasby VP, Regulatory and Clinical $124K Jun 17, 2021
Michael Geltzeiler Director $111K Jun 12, 2024
Michael Rowe Chief Executive Officer, Director $102K +$53.5K +111% Aug 28, 2024
Kenneth B. Lee Jr Director $87.8K Jun 16, 2022
Curt H. LaBelle Director $57.4K Nov 17, 2021
Julia A. Haller Director $41.4K Jun 16, 2022
Anthony Y. Sun Director $35.8K Nov 17, 2021
Stephen Keith Benjamin Director $34.7K Jun 16, 2022
John P. Gandolfo Chief Financial Officer $10.9K Feb 12, 2024
Bren Kern Chief Operating Officer $3.4K Feb 12, 2024
Luke Clauson VP Research & Development Jun 16, 2021
Andrew D. Jones Chief Financial Officer Aug 30, 2024

Recent Insider Transactions by Companies or Individuals for Eyenovia, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.